Brain Awareness Week, CoVID-19 infection and Neurological Sciences.
作者信息
Federico Antonio
机构信息
Department Medicine, Surgery an Neurosciences, Medical School, University of Siena, Viale Bracci 2, 53100, Siena, Italy.
出版信息
Neurol Sci. 2020 Apr;41(4):747-748. doi: 10.1007/s10072-020-04338-0.
Abstract
摘要
相似文献
1
Brain Awareness Week, CoVID-19 infection and Neurological Sciences.脑健康周、新冠病毒感染与神经科学
Neurol Sci. 2020 Apr;41(4):747-748. doi: 10.1007/s10072-020-04338-0.
2
Keeping the Wheels of the Scientific Endeavor Turning during the COVID-19 Pandemic.在新冠疫情期间推动科学事业的车轮继续转动
Cell Syst. 2020 Apr 22;10(4):307. doi: 10.1016/j.cels.2020.03.007. Epub 2020 Apr 7.
3
The COVID-19 Pandemic and the JAMA Network.新冠疫情与《美国医学会杂志》网络
JAMA. 2020 Sep 22;324(12):1159-1160. doi: 10.1001/jama.2020.18298.
4
COVID-19: looking forward.2019冠状病毒病：展望未来。
Intern Med J. 2020 Jun;50(6):657. doi: 10.1111/imj.14865. Epub 2020 Apr 29.
5
The role of human biology in addressing the COVID-19 pandemic.人类生物学在应对新冠疫情中的作用。
Am J Hum Biol. 2020 May;32(3):e23430. doi: 10.1002/ajhb.23430. Epub 2020 May 6.
6
COVID-19: a catalyst for flexibility and creativity in neurology.新冠疫情：神经学灵活性与创造力的催化剂
Lancet Neurol. 2020 Jul;19(7):557. doi: 10.1016/S1474-4422(20)30176-9.
7
Crisis Management by Journal Editors: Case of COVID-19.期刊编辑的危机管理：以COVID-19为例
J Korean Med Sci. 2020 Sep 21;35(37):e320. doi: 10.3346/jkms.2020.35.e320.
8
Journal Flexibility in the Troubling Times of COVID-19.《COVID-19疫情艰难时期的期刊灵活性》
Plant Physiol. 2020 Apr;182(4):1795. doi: 10.1104/pp.20.00347.
9
COVID-19 is catalyzing the adoption of teleneurology.新冠疫情正在推动远程神经病学的应用。
Neurology. 2020 May 26;94(21):903-904. doi: 10.1212/WNL.0000000000009494. Epub 2020 Apr 1.
10
COVID-19.新型冠状病毒肺炎
Soc Stud Sci. 2020 Apr;50(2):173-174. doi: 10.1177/0306312720918403.
引用本文的文献
1
Neurologic Manifestations of COVID-19.新型冠状病毒肺炎的神经系统表现。
Adv Exp Med Biol. 2021;1318:343-353. doi: 10.1007/978-3-030-63761-3_20.
2
SAMHD1 as the Potential Link Between SARS-CoV-2 Infection and Neurological Complications.SAMHD1作为严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染与神经并发症之间的潜在联系。
Front Neurol. 2020 Sep 25;11:562913. doi: 10.3389/fneur.2020.562913. eCollection 2020.
3
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections.SARS-CoV-2 感染的自然史、病理学和临床表现。
J Neuroimmune Pharmacol. 2020 Sep;15(3):359-386. doi: 10.1007/s11481-020-09944-5. Epub 2020 Jul 21.
4
Neurological manifestations and implications of COVID-19 pandemic.2019冠状病毒病大流行的神经学表现及影响
Ther Adv Neurol Disord. 2020 Jun 9;13:1756286420932036. doi: 10.1177/1756286420932036. eCollection 2020.
5
Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey.由于新冠疫情，未来5年神经科护理会发生变化吗？关键信息提供者共识调查。
Neurologia (Engl Ed). 2020 May;35(4):252-257. doi: 10.1016/j.nrl.2020.04.006. Epub 2020 Apr 18.
本文引用的文献
1
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle.遗传性神经肌肉疾病：治疗革命时代的生活。第 2 部分：运动神经元和骨骼肌疾病。
Neurol Sci. 2019 Apr;40(4):671-681. doi: 10.1007/s10072-019-03764-z. Epub 2019 Feb 25.
2
Stroke during sleep and obstructive sleep apnea: there is a link.睡眠中发生的中风与阻塞性睡眠呼吸暂停：二者存在关联。
Neurol Sci. 2019 May;40(5):1001-1005. doi: 10.1007/s10072-019-03753-2. Epub 2019 Feb 13.
3
Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.携带 C9orf72 突变患者脑 FDG-PET 代谢的异质性模式。
Neurol Sci. 2019 Mar;40(3):515-521. doi: 10.1007/s10072-018-3685-7. Epub 2018 Dec 15.
4
Efficacy and safety of edaravone in treatment of amyotrophic lateral sclerosis-a systematic review and meta-analysis.依达拉奉治疗肌萎缩侧索硬化症的疗效和安全性：系统评价和荟萃分析。
Neurol Sci. 2019 Feb;40(2):235-241. doi: 10.1007/s10072-018-3653-2. Epub 2018 Nov 27.
5
Intrathecal nusinersen treatment for SMA in a dedicated neuromuscular clinic: an example of multidisciplinary and integrated care.鞘内注射 nusinersen 治疗专设神经肌肉诊所中的 SMA：多学科和综合治疗的范例。
Neurol Sci. 2019 Feb;40(2):327-332. doi: 10.1007/s10072-018-3622-9. Epub 2018 Nov 15.
6
The Italian multiple sclerosis register.意大利多发性硬化症登记处。
Neurol Sci. 2019 Jan;40(1):155-165. doi: 10.1007/s10072-018-3610-0. Epub 2018 Nov 13.
7
Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.纹状体 12 个亚区的详细 PET 分析：帕金森病患者多巴胺转运体丢失与非运动症状之间缺乏关联。
Neurol Sci. 2019 Feb;40(2):311-317. doi: 10.1007/s10072-018-3632-7. Epub 2018 Nov 10.
8
Microbial treatment: the potential application for Parkinson's disease.微生物治疗：帕金森病的潜在应用。
Neurol Sci. 2019 Jan;40(1):51-58. doi: 10.1007/s10072-018-3641-6. Epub 2018 Nov 10.
9
Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson's disease.在受特发性帕金森病影响的患者队列中，沙芬酰胺对非运动症状的疗效。
Neurol Sci. 2019 Feb;40(2):275-279. doi: 10.1007/s10072-018-3628-3. Epub 2018 Oct 31.
10
Replication study of GWAS risk loci in Greek multiple sclerosis patients.GWAS 风险基因座在希腊多发性硬化症患者中的复制研究。
Neurol Sci. 2019 Feb;40(2):253-260. doi: 10.1007/s10072-018-3617-6. Epub 2018 Oct 26.
Zotero 插件